Depletion of 4E-BP1 and regulation of autophagy lead to YXM110-induced anticancer effects

Chin Yu Lai, Shiow Lin Pan, Xiao Ming Yang, Li Hsun Chang, Ya Ling Chang, Pan Chyr Yang, Kuo Hsiung Lee, Che Ming Teng

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Natural products have always been a profuse database for developing new chemotherapeutics. YXM110 is a newly synthesized phenanthroquinolizidines that exhibits excellent anticancer activity in numerous cancer cells. In this study, we examined the anticancer mechanisms of YXM110 both in vitro and in vivo. Protein level of 4E-binding protein 1, which is crucial in cap-independent translation, was decreased significantly after YXM110treatment via c-Jun N-terminal kinases-mediated proteasomal degradation. Moreover, the effects of YXM110 were associated with several characteristics of autophagy, including accumulation of autophagic vacuoles, elevation of Atg12-Atg5 and light chain 3 (LC3)-II, and levels of GFP-LC3 puncta. The results suggested that depletion of Mcl-1 contributes to YXM110-triggered autophagy, whereas downregulation of lysosomal-related genes could cause autophagy impairment. Furthermore, YXM110-induced cell death was prevented by autophagy inhibitor 3-methyladenine and Atg5 silencing, indicating that YXM110-mediatedautophagy impairment leads to cancer cell death. These data reveal key mechanisms that support the further development of YXM110 as a promising anticancer agent.

Original languageEnglish
Pages (from-to)2050-2060
Number of pages11
JournalCarcinogenesis
Volume34
Issue number9
DOIs
Publication statusPublished - Sep 2013

Fingerprint

Autophagy
Cell Death
Light
JNK Mitogen-Activated Protein Kinases
Vacuoles
YXM110
Biological Products
Antineoplastic Agents
Neoplasms
Carrier Proteins
Down-Regulation
Databases
Genes
Proteins

ASJC Scopus subject areas

  • Cancer Research

Cite this

Lai, C. Y., Pan, S. L., Yang, X. M., Chang, L. H., Chang, Y. L., Yang, P. C., ... Teng, C. M. (2013). Depletion of 4E-BP1 and regulation of autophagy lead to YXM110-induced anticancer effects. Carcinogenesis, 34(9), 2050-2060. https://doi.org/10.1093/carcin/bgt146

Depletion of 4E-BP1 and regulation of autophagy lead to YXM110-induced anticancer effects. / Lai, Chin Yu; Pan, Shiow Lin; Yang, Xiao Ming; Chang, Li Hsun; Chang, Ya Ling; Yang, Pan Chyr; Lee, Kuo Hsiung; Teng, Che Ming.

In: Carcinogenesis, Vol. 34, No. 9, 09.2013, p. 2050-2060.

Research output: Contribution to journalArticle

Lai, CY, Pan, SL, Yang, XM, Chang, LH, Chang, YL, Yang, PC, Lee, KH & Teng, CM 2013, 'Depletion of 4E-BP1 and regulation of autophagy lead to YXM110-induced anticancer effects', Carcinogenesis, vol. 34, no. 9, pp. 2050-2060. https://doi.org/10.1093/carcin/bgt146
Lai, Chin Yu ; Pan, Shiow Lin ; Yang, Xiao Ming ; Chang, Li Hsun ; Chang, Ya Ling ; Yang, Pan Chyr ; Lee, Kuo Hsiung ; Teng, Che Ming. / Depletion of 4E-BP1 and regulation of autophagy lead to YXM110-induced anticancer effects. In: Carcinogenesis. 2013 ; Vol. 34, No. 9. pp. 2050-2060.
@article{a0c28e41772a40a798cf432360d36542,
title = "Depletion of 4E-BP1 and regulation of autophagy lead to YXM110-induced anticancer effects",
abstract = "Natural products have always been a profuse database for developing new chemotherapeutics. YXM110 is a newly synthesized phenanthroquinolizidines that exhibits excellent anticancer activity in numerous cancer cells. In this study, we examined the anticancer mechanisms of YXM110 both in vitro and in vivo. Protein level of 4E-binding protein 1, which is crucial in cap-independent translation, was decreased significantly after YXM110treatment via c-Jun N-terminal kinases-mediated proteasomal degradation. Moreover, the effects of YXM110 were associated with several characteristics of autophagy, including accumulation of autophagic vacuoles, elevation of Atg12-Atg5 and light chain 3 (LC3)-II, and levels of GFP-LC3 puncta. The results suggested that depletion of Mcl-1 contributes to YXM110-triggered autophagy, whereas downregulation of lysosomal-related genes could cause autophagy impairment. Furthermore, YXM110-induced cell death was prevented by autophagy inhibitor 3-methyladenine and Atg5 silencing, indicating that YXM110-mediatedautophagy impairment leads to cancer cell death. These data reveal key mechanisms that support the further development of YXM110 as a promising anticancer agent.",
author = "Lai, {Chin Yu} and Pan, {Shiow Lin} and Yang, {Xiao Ming} and Chang, {Li Hsun} and Chang, {Ya Ling} and Yang, {Pan Chyr} and Lee, {Kuo Hsiung} and Teng, {Che Ming}",
year = "2013",
month = "9",
doi = "10.1093/carcin/bgt146",
language = "English",
volume = "34",
pages = "2050--2060",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Depletion of 4E-BP1 and regulation of autophagy lead to YXM110-induced anticancer effects

AU - Lai, Chin Yu

AU - Pan, Shiow Lin

AU - Yang, Xiao Ming

AU - Chang, Li Hsun

AU - Chang, Ya Ling

AU - Yang, Pan Chyr

AU - Lee, Kuo Hsiung

AU - Teng, Che Ming

PY - 2013/9

Y1 - 2013/9

N2 - Natural products have always been a profuse database for developing new chemotherapeutics. YXM110 is a newly synthesized phenanthroquinolizidines that exhibits excellent anticancer activity in numerous cancer cells. In this study, we examined the anticancer mechanisms of YXM110 both in vitro and in vivo. Protein level of 4E-binding protein 1, which is crucial in cap-independent translation, was decreased significantly after YXM110treatment via c-Jun N-terminal kinases-mediated proteasomal degradation. Moreover, the effects of YXM110 were associated with several characteristics of autophagy, including accumulation of autophagic vacuoles, elevation of Atg12-Atg5 and light chain 3 (LC3)-II, and levels of GFP-LC3 puncta. The results suggested that depletion of Mcl-1 contributes to YXM110-triggered autophagy, whereas downregulation of lysosomal-related genes could cause autophagy impairment. Furthermore, YXM110-induced cell death was prevented by autophagy inhibitor 3-methyladenine and Atg5 silencing, indicating that YXM110-mediatedautophagy impairment leads to cancer cell death. These data reveal key mechanisms that support the further development of YXM110 as a promising anticancer agent.

AB - Natural products have always been a profuse database for developing new chemotherapeutics. YXM110 is a newly synthesized phenanthroquinolizidines that exhibits excellent anticancer activity in numerous cancer cells. In this study, we examined the anticancer mechanisms of YXM110 both in vitro and in vivo. Protein level of 4E-binding protein 1, which is crucial in cap-independent translation, was decreased significantly after YXM110treatment via c-Jun N-terminal kinases-mediated proteasomal degradation. Moreover, the effects of YXM110 were associated with several characteristics of autophagy, including accumulation of autophagic vacuoles, elevation of Atg12-Atg5 and light chain 3 (LC3)-II, and levels of GFP-LC3 puncta. The results suggested that depletion of Mcl-1 contributes to YXM110-triggered autophagy, whereas downregulation of lysosomal-related genes could cause autophagy impairment. Furthermore, YXM110-induced cell death was prevented by autophagy inhibitor 3-methyladenine and Atg5 silencing, indicating that YXM110-mediatedautophagy impairment leads to cancer cell death. These data reveal key mechanisms that support the further development of YXM110 as a promising anticancer agent.

UR - http://www.scopus.com/inward/record.url?scp=84887006467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887006467&partnerID=8YFLogxK

U2 - 10.1093/carcin/bgt146

DO - 10.1093/carcin/bgt146

M3 - Article

VL - 34

SP - 2050

EP - 2060

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 9

ER -